Company

Greywolf Therapeutics

Biotechnology Research Milton, Kent, United Kingdom 51 employees

Employees: 51
Contacts: 2
Emails: 2

greywolftherapeutics.com LinkedIn

Greywolf Therapeutics Overview

Headquarters: Milton, Kent, United Kingdom
Website: greywolftherapeutics.com
Industry: Biotechnology Research
Employees: 51
Founded: 2017
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

are driving innovation in drug development:

About Greywolf Therapeutics

Many diseases are caused, or resist treatment, because T cells can't recognize or target cells correctly. We're progressing first-in-class antigen modulators through the clinic, developed to treat disease by controlling T cell activation. Our approach modulates antigen presentation, flicking a switch inside cells to alter their appearance to the immune system. This marks a fundamental shift in how we treat people living with autoimmune disorders, cancers and infectious diseases.

Greywolf Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage

Greywolf Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Jo Hume	VP Finance at Greywolf Therapeutics		View
Marie-Claire Peakman	Partner, Pfizer Ventures - Executive Director, Worldwide Business Development, Pfizer Inc.	United States	Email
Tanya Palmer	Clinical Operations Lead	Tingewick, England, United Kingdom	Email
Tracy Weightman	Life Science Venture Capital		View